Cargando…

An analysis of completeness and quality of adverse drug reaction reports at an adverse drug reaction monitoring centre in Western India

PURPOSE/AIM: The Adverse Drug Reaction [ADR] form is the source document for the Pharmacovigilance Programme of India [PvPI] and captures information first hand from the patient. The raw data from it then gets converted into an individual case safety report [ICSR] after entry into Vigiflow. The Nati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahajan, Manali Mangesh, Thatte, Urmila Mukund, Gogtay, Nithya Jaideep, Deshpande, Siddharth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058509/ https://www.ncbi.nlm.nih.gov/pubmed/30090710 http://dx.doi.org/10.4103/picr.PICR_105_17

Ejemplares similares

Compliance of Mumbai-based clinical trial sites with the Quality Council of India guidelines and evaluation of the challenges faced by the investigators
por: Figer, Brinal, et al.
Publicado: (2021)

Evaluation of clinical trials done for orphan drugs versus nonorphan drugs in infectious diseasesan eleven year analysis [2010-2020]
por: Kudyar, Palvi, et al.
Publicado: (2023)

An audit of the approval letters issued by Drugs Controller General of India to Ethics Committees in India
por: Bhide, Shruti S., et al.
Publicado: (2016)

Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study
por: Sharma, Megha, et al.
Publicado: (2021)

Fatal adverse drug reactions: Experience of adverse drug reactions in a tertiary care teaching hospital of North India - A case series
por: Tandon, Vishal R., et al.
Publicado: (2014)

An audit of institutional ethics committee queries raised after initial project submission by a single research department at a tertiary referral center in India
por: Raj, Jeffrey Pradeep, et al.
Publicado: (2023)

Under-reporting of adverse drug reactions: A challenge for pharmacovigilance in India
por: Tandon, Vishal R., et al.
Publicado: (2015)

Adverse Drug Reactions
por: Turner, Paul
Publicado: (1988)

Adverse Drug Reactions
por: Criado, Paulo Ricardo
Publicado: (2016)

An evaluation of the minutes of subject expert committee meetings of novel COVID-19 proposals
por: Raj, Jeffrey Pradeep, et al.
Publicado: (2022)

Completeness of adverse drug reactions reports of the Saudi adverse event reporting system
por: Alshammari, Thamir M., et al.
Publicado: (2015)

Adverse drug reactions due to ophthalmic drugs: Reporting system in India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2016)

Mining drug–target and drug–adverse drug reaction databases to identify target–adverse drug reaction relationships
por: Galletti, Cristiano, et al.
Publicado: (2021)

Textbook of adverse drug reactions /
Publicado: (1977)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

Adverse drug reactions in the elderly
por: Brahma, Dhriti K., et al.
Publicado: (2013)

Pharmacogenomics of adverse drug reactions
por: Daly, Ann K
Publicado: (2013)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

The Detection of Adverse Drug Reactions
por: Crooks, James
Publicado: (1977)

Textbook of Adverse Drug Reactions
por: George, Charles F.
Publicado: (1992)

Evaluation of vanillin as a probe drug for aldehyde oxidase and phenotyping for its activity in a Western Indian Cohort
por: Subash, Sandhya, et al.
Publicado: (2021)

Determination of reference intervals from a laboratory database of an academic clinical research unit in a tertiary care teaching hospital and an audit of out of range values
por: Figer, Brinal H., et al.
Publicado: (2021)

Association of Bacillus Calmette Guerin Vaccine Strains with COVID-19 Morbidity and Mortality – Evaluation of Global Data
por: Chaudhari, Vijaya Laxman, et al.
Publicado: (2021)

Do clinical trials conducted in India match its healthcare needs? An audit of the Clinical Trials Registry of India
por: Chaturvedi, Mansi, et al.
Publicado: (2017)

Adverse drug reactions reporting culture in Pharmacovigilance Programme of India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2014)

Antipsychotic Drug Utilization and Adverse Drug Reaction Profiling in Patients With Schizophrenia at a Tertiary Care Hospital in Western India
por: Tripathi, Raakhi K, et al.
Publicado: (2022)

A two-year evaluation of the minutes of Investigational New Drug committee meetings
por: Raj, Jeffrey Pradeep, et al.
Publicado: (2021)

Knowledge about clinical trial agreement and clinical trial related insurance among Ethics Committee members: A cross-sectional survey
por: Sridharan, Kannan, et al.
Publicado: (2016)

Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions – A Meta-Analysis
por: Hakkarainen, Katja M., et al.
Publicado: (2012)

Drug–drug–gene interactions and adverse drug reactions
por: Malki, Mustafa Adnan, et al.
Publicado: (2019)

Regulatory requirements for clinical trials in India: What academicians need to know
por: Gogtay, Nithya J, et al.
Publicado: (2017)

Children and ADRs (Adverse Drug Reactions)
por: Napoleone, Ettore
Publicado: (2010)

Focus on headache as an adverse reaction to drugs
por: Ferrari, Anna, et al.
Publicado: (2009)

Pharmacogenomics and adverse drug reactions in children
por: Rieder, Michael J., et al.
Publicado: (2014)

Ranking Adverse Drug Reactions With Crowdsourcing
por: Gottlieb, Assaf, et al.
Publicado: (2015)

Epidemiology of cutaneous adverse drug reactions
por: Mockenhaupt, M.
Publicado: (2017)

Levetiracetam Adverse Drug Reaction: Pancytopenia
por: Gohil, Jayendra R., et al.
Publicado: (2018)

Metabolic Basis of Adverse Drug Reactions
por: Park, B.K.
Publicado: (1986)

MRGPRX2 and Adverse Drug Reactions
por: McNeil, Benjamin D.
Publicado: (2021)

Editorial: The Immunology of Adverse Drug Reactions
por: Illing, Patricia T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c8oovcgk7ccaqte4dtjiv9cnna